EPA:EQS - Euronext Paris - Matif - FR0012882389 - Common Stock - Currency: EUR
EPA:EQS (7/16/2025, 5:25:34 PM)
50.4
-1.4 (-2.7%)
The current stock price of EQS.PA is 50.4 EUR. In the past month the price increased by 9.4%. In the past year, price increased by 5.71%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
NXU.DE | NEXUS AG | 37.77 | 1.23B | ||
GPI.MI | GPI SPA | 3.56 | 369.47M | ||
CONTX.OL | CONTEXTVISION AB | 24.56 | 341.98M | ||
AGFB.BR | AGFA-GEVAERT NV | N/A | 156.06M | ||
CGM.PA | CEGEDIM SA | N/A | 148.05M | ||
AJ91.DE | DOCCHECK AG | 12.02 | 63.38M | ||
M3V.DE | MEVIS MEDICAL SOLUTIONS AG | 9.92 | 45.14M | ||
ALMDT.PA | MEDIAN TECHNOLOGIES | N/A | 44.02M | ||
ALINS.PA | INTRASENSE SAS | N/A | 15.03M | ||
MLLAB.PA | MEDIA LAB SPA | N/A | 8.11M |
Equasens engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in publishing and integration of software packages intended for pharmacies, hospitals, health establishments, laboratories, retirement homes and health professionals. Its activity is distributed in publishing and integration of software packages for pharmacies, publishing of IT solutions for health and medico-social establishments and development of solutions and infrastructure for e-Health. The company provides software packages for managing databases, information, stocks, orders, electronic care sheets, etc. The company offers publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, invoicing, tracking collections and accounting, care monitoring, stewardship management, etc. );
EQUASENS
5 Allee de Saint-Cloud
Villers-les-Nancy GRAND EST FR
Employees: 1271
Phone: 33383159595
The current stock price of EQS.PA is 50.4 EUR. The price decreased by -2.7% in the last trading session.
The exchange symbol of EQUASENS is EQS and it is listed on the Euronext Paris - Matif exchange.
EQS.PA stock is listed on the Euronext Paris - Matif exchange.
7 analysts have analysed EQS.PA and the average price target is 58.14 EUR. This implies a price increase of 15.36% is expected in the next year compared to the current price of 50.4. Check the EQUASENS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
EQUASENS (EQS.PA) has a market capitalization of 764.57M EUR. This makes EQS.PA a Small Cap stock.
EQUASENS (EQS.PA) currently has 1271 employees.
EQUASENS (EQS.PA) has a support level at 51.58 and a resistance level at 51.81. Check the full technical report for a detailed analysis of EQS.PA support and resistance levels.
The Revenue of EQUASENS (EQS.PA) is expected to grow by 9.26% in the next year. Check the estimates tab for more information on the EQS.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
EQUASENS (EQS.PA) has a dividend yield of 2.49%. The yearly dividend amount is currently 1.25. Check the full fundamental report for a detailed analysis of EQS.PA dividend history, reliability and sustainability.
EQUASENS (EQS.PA) will report earnings on 2025-07-31.
The PE ratio for EQUASENS (EQS.PA) is 21.09. This is based on the reported non-GAAP earnings per share of 2.39 and the current share price of 50.4 EUR. Check the full fundamental report for a full analysis of the valuation metrics for EQS.PA.
ChartMill assigns a technical rating of 9 / 10 to EQS.PA. When comparing the yearly performance of all stocks, EQS.PA is one of the better performing stocks in the market, outperforming 87.19% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA. EQS.PA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months EQS.PA reported a non-GAAP Earnings per Share(EPS) of 2.39. The EPS decreased by -23.02% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 16.72% | ||
ROA | 9.1% | ||
ROE | 15.65% | ||
Debt/Equity | 0.12 |
ChartMill assigns a Buy % Consensus number of 80% to EQS.PA. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 27.31% and a revenue growth 9.26% for EQS.PA